These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35133567)

  • 1. A PRO-cision medicine intervention to personalize cancer care using patient-reported outcomes: intervention development and feasibility-testing.
    Snyder C; Hannum SM; White S; Montanari A; Ikejiani D; Smith B; Blackford A; Thorner E; Smith KC; Carducci MA; Stearns V; Smith KL
    Qual Life Res; 2022 Aug; 31(8):2341-2355. PubMed ID: 35133567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electronic patient-reported outcomes monitoring during lung cancer chemotherapy: A nested cohort within the PRO-TECT pragmatic trial (AFT-39).
    Mody GN; Stover AM; Wang M; King-Kallimanis BL; Jansen J; Henson S; Chung AE; Jonsson M; Bennett A; Smith AB; Wood WA; Deal A; Ginos B; Dueck AC; Schrag D; Basch E
    Lung Cancer; 2021 Dec; 162():1-8. PubMed ID: 34634754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilizing Digital Health to Collect Electronic Patient-Reported Outcomes in Prostate Cancer: Single-Arm Pilot Trial.
    Tran C; Dicker A; Leiby B; Gressen E; Williams N; Jim H
    J Med Internet Res; 2020 Mar; 22(3):e12689. PubMed ID: 32209536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A PRO-cision Medicine Methods Toolkit to Address the Challenges of Personalizing Cancer Care Using Patient-Reported Outcomes: Introduction to the Supplement.
    Snyder C; Brundage M; Rivera YM; Wu AW
    Med Care; 2019 May; 57 Suppl 5 Suppl 1(Suppl 5 1):S1-S7. PubMed ID: 30985589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Electronic Symptom Monitoring on Patient-Reported Outcomes Among Patients With Metastatic Cancer: A Randomized Clinical Trial.
    Basch E; Schrag D; Henson S; Jansen J; Ginos B; Stover AM; Carr P; Spears PA; Jonsson M; Deal AM; Bennett AV; Thanarajasingam G; Rogak LJ; Reeve BB; Snyder C; Bruner D; Cella D; Kottschade LA; Perlmutter J; Geoghegan C; Samuel-Ryals CA; Given B; Mazza GL; Miller R; Strasser JF; Zylla DM; Weiss A; Blinder VS; Dueck AC
    JAMA; 2022 Jun; 327(24):2413-2422. PubMed ID: 35661856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. eHealth System for Collecting and Utilizing Patient Reported Outcome Measures for Personalized Treatment and Care (PROMPT-Care) Among Cancer Patients: Mixed Methods Approach to Evaluate Feasibility and Acceptability.
    Girgis A; Durcinoska I; Levesque JV; Gerges M; Sandell T; Arnold A; Delaney GP;
    J Med Internet Res; 2017 Oct; 19(10):e330. PubMed ID: 28970188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-reported outcomes (PRO) focused on adverse events (PRO-AEs) in adjuvant and metastatic breast cancer: clinical and translational implications.
    Stefanovic S; Wallwiener M; Karic U; Domschke C; Katic L; Taran FA; Pesic A; Hartkopf A; Hadji P; Teufel M; Schuetz F; Sohn C; Fasching P; Schneeweiss A; Brucker S
    Support Care Cancer; 2017 Feb; 25(2):549-558. PubMed ID: 27747478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoting effective use of patient-reported outcomes in clinical practice: themes from a "Methods Tool kit" paper series.
    Brundage MD; Wu AW; Rivera YM; Snyder C
    J Clin Epidemiol; 2020 Jun; 122():153-159. PubMed ID: 32061828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-Reported Outcomes During Immunotherapy for Metastatic Melanoma: Mixed Methods Study of Patients' and Clinicians' Experiences.
    Tolstrup LK; Pappot H; Bastholt L; Zwisler AD; Dieperink KB
    J Med Internet Res; 2020 Apr; 22(4):e14896. PubMed ID: 32271150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. When using patient-reported outcomes in clinical practice, the measure matters: a randomized controlled trial.
    Snyder CF; Herman JM; White SM; Luber BS; Blackford AL; Carducci MA; Wu AW
    J Oncol Pract; 2014 Sep; 10(5):e299-306. PubMed ID: 24986113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using Stakeholder Engagement to Overcome Barriers to Implementing Patient-reported Outcomes (PROs) in Cancer Care Delivery: Approaches From 3 Prospective Studies.
    Stover AM; Tompkins Stricker C; Hammelef K; Henson S; Carr P; Jansen J; Deal AM; Bennett AV; Basch EM
    Med Care; 2019 May; 57 Suppl 5 Suppl 1():S92-S99. PubMed ID: 30985602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving an electronic system for measuring PROs in routine oncology practice.
    Wu AW; White SM; Blackford AL; Wolff AC; Carducci MA; Herman JM; Snyder CF;
    J Cancer Surviv; 2016 Jun; 10(3):573-82. PubMed ID: 26644190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PRO B: evaluating the effect of an alarm-based patient-reported outcome monitoring compared with usual care in metastatic breast cancer patients-study protocol for a randomised controlled trial.
    Karsten MM; Kühn F; Pross T; Blohmer JU; Hage AM; Fischer F; Rose M; Grittner U; Gebert P; Ferencz J; Pauler L; Breidenbach C; Kowalski C;
    Trials; 2021 Sep; 22(1):666. PubMed ID: 34583744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acceptability of Routine Evaluations Using Patient-Reported Outcomes of Common Terminology Criteria for Adverse Events and Other Patient-Reported Symptom Outcome Tools in Cancer Outpatients: Princess Margaret Cancer Centre Experience.
    Albaba H; Barnes TA; Veitch Z; Brown MC; Shakik S; Su S; Naik H; Wang T; Liang M; Perez-Cosio A; Eng L; Mittmann N; Xu W; Howell D; Liu G
    Oncologist; 2019 Nov; 24(11):e1219-e1227. PubMed ID: 31409744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Digital Monitoring and Management of Patients With Advanced or Metastatic Non-Small Cell Lung Cancer Treated With Cancer Immunotherapy and Its Impact on Quality of Clinical Care: Interview and Survey Study Among Health Care Professionals and Patients.
    Schmalz O; Jacob C; Ammann J; Liss B; Iivanainen S; Kammermann M; Koivunen J; Klein A; Popescu RA
    J Med Internet Res; 2020 Dec; 22(12):e18655. PubMed ID: 33346738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of a Remote Monitoring Program for Symptoms Among Adults With Cancer Receiving Antineoplastic Therapy.
    Daly B; Nicholas K; Flynn J; Silva N; Panageas K; Mao JJ; Gazit L; Gorenshteyn D; Sokolowski S; Newman T; Perry C; Wagner I; Zervoudakis A; Salvaggio R; Holland J; Chiu YO; Kuperman GJ; Simon BA; Reidy-Lagunes DL; Perchick W
    JAMA Netw Open; 2022 Mar; 5(3):e221078. PubMed ID: 35244701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrative Oncology Consultations Delivered via Telehealth in 2020 and In-Person in 2019: Paradigm Shift During the COVID-19 World Pandemic.
    Narayanan S; Lopez G; Powers-James C; Fellman BM; Chunduru A; Li Y; Bruera E; Cohen L
    Integr Cancer Ther; 2021; 20():1534735421999101. PubMed ID: 33655797
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.